Archives of Pharmacal Research

Papers
(The H4-Index of Archives of Pharmacal Research is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Ubiquitin–proteasome system (UPS) as a target for anticancer treatment208
Phytochemistry and pharmacological activity of the genus artemisia99
Pathological angiogenesis and inflammation in tissues89
Astragalus polysaccharide: a review of its immunomodulatory effect87
Biomedical features and therapeutic potential of rosmarinic acid84
Mechanisms of resistance to chemotherapy in non-small cell lung cancer77
Aldose Reductase: a cause and a potential target for the treatment of diabetic complications74
Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases69
Skin barrier dysfunction and filaggrin69
Pharmacological effects of harmine and its derivatives: a review68
Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective54
Understanding of sarcopenia: from definition to therapeutic strategies54
Phytochemical and pharmacological properties of Myristica fragrans Houtt.: an updated review47
Crosstalk between angiogenesis and immune regulation in the tumor microenvironment46
Biological roles of cytochrome P450 1A1, 1A2, and 1B1 enzymes43
Ginkwanghols A and B, osteogenic coumaric acid-aliphatic alcohol hybrids from the leaves of Ginkgo biloba41
Flavonoids as therapeutic candidates for emotional disorders such as anxiety and depression38
The role of mucosal barriers in human gut health38
mRNA vaccines: the most recent clinical applications of synthetic mRNA37
Role of specialized pro-resolving lipid mediators and their receptors in virus infection: a promising therapeutic strategy for SARS-CoV-2 cytokine storm37
Recent advances in the pathology of prodromal non-motor symptoms olfactory deficit and depression in Parkinson’s disease: clues to early diagnosis and effective treatment36
The role of epithelial–mesenchymal transition-regulating transcription factors in anti-cancer drug resistance35
Role of mitochondrial dynamics and mitophagy of vascular smooth muscle cell proliferation and migration in progression of atherosclerosis35
Ginsenoside-Rg2 exerts anti-cancer effects through ROS-mediated AMPK activation associated mitochondrial damage and oxidation in MCF-7 cells34
Protective effects of ginsenoside-Rg2 and -Rh1 on liver function through inhibiting TAK1 and STAT3-mediated inflammatory activity and Nrf2/ARE-mediated antioxidant signaling pathway33
Atractylenolides (I, II, and III): a review of their pharmacology and pharmacokinetics32
Latest research progress on anticancer effect of baicalin and its aglycone baicalein31
Fibroblast growth factor 2 exacerbates inflammation in adipocytes through NLRP3 inflammasome activation31
Recent advances in selective and targeted drug/gene delivery systems using cell-penetrating peptides31
Is loss of smell an early predictor of COVID-19 severity: a systematic review and meta-analysis30
0.05999493598938